Overlap between neurodegenerative disorders

Neuropathology

Volumn 25, Issue 2, 2005, Pages 111-124

  Armstrong, Richard A ^a   Lantos, Peter L ^b   Cairns, Nigel J ^c,d  

^a ASTON UNIVERSITY   (United Kingdom)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d WASHINGTON UNIVERSITY   (United States)

Author keywords

synucleinopathy; Brain lesion; Disease heterogeneity; Neurodegenerative disorder; Nosology; Tauopathy

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN; APOLIPOPROTEIN E4;

AGE; ALZHEIMER DISEASE; CELL INCLUSION; CELL STRUCTURE; CLINICAL FEATURE; COMORBIDITY; CORTICOBASAL DEGENERATION; DEGENERATIVE DISEASE; DEMENTIA; DIFFUSE LEWY BODY DISEASE; DISEASE CLASSIFICATION; FRONTOTEMPORAL DEMENTIA; GENE EXPRESSION; GENE LOCUS; GENE MUTATION; GENOTYPE; HISTOPATHOLOGY; HISTORY OF MEDICINE; HUMAN; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PHENOTYPE; PICK PRESENILE DEMENTIA; PRION DISEASE; PRIORITY JOURNAL; PROTEIN DETERMINATION; REVIEW; RISK FACTOR;

BRAIN; HUMANS; NEURODEGENERATIVE DISEASES;

EID: 17644422180     PISSN: 09196544     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1789.2005.00605.x     Document Type: Review

References (150)

1. Graeber MB, Kosel S, Egensperger R et al. Rediscovery of the case described by Alois Alzheimer in 1911: historical, histological and molecular genetic analysis. Neurogenetics 1997; 1: 73-80.
2. Forstl H. The Lewy body variant of Alzheimer's disease: clinical, pathophysiological and conceptual issues. Eur Arch Psychiatry Clin Neurosci 1999; 249: 64-67.
3. Duckett S, Stern J. Origins of the Creutzfeldt and Jakob concept. J Hist Neurosci 1999; 8: 21-34.
4. Hainfellner JA, Aanschutz J, Jellinger K, Liberski PP, Gullotta F, Budka H. Coexistence of Alzheimer type neuropathology in Creutzfeldt-Jakob disease. Acta Neuropathol 1998; 96: 116-122.
5. Feany MB, Dickson DW. Neurodegenerative disorders with extensive tau pathology: a comparative study and review. Ann Neurol 1996; 40: 139-148.
6. Perl DP, Olanow CW, Calne D. Alzheimer's disease and Parkinson's disease: distinct entities or extremes of a spectrum of neurodegeneration? Ann Neurol 1998; 44 (3 Suppl 1): S19-S31.
7. Morris JC. The nosology of dementia. Neurol Clin 2000; 18: 773-788.
8. Drouet B, Pincon-Raymond M, Chambaz J, Pillot T. Molecular basis of Alzheimer's disease. Cell Mol Life Sci 2000; 57: 705-715.
9. Forstl H. Alzheimer's disease: the size of the problem, clinical manifestation and heterogeneity. J Neurol Transm 1998; 54: 1-8.
10. Delaere P, Duyckaerts C, He Y, Piette F, Hauw JJ. Subtypes and differential laminar distribution of β/A4 deposits in Alzheimer's disease: relationship with the intellectual status of 26 cases. Acta Neuropathol 1991; 81: 328-335.
11. Armstrong RA. β-amyloid plaques: stages in life history or independent origin? Dement Geriatr Cogn Disord 1998; 9: 227-238.
12. Glenner GG, Wong CW. Alzheimer's disease and Down's syndrome: sharing of a unique cerebrovascular amyloid fibril protein. Biochem Biophys Res Commun 1984; 122: 1131-1135.
13. Yamaguchi H, Ishigura K, Sugihara S et al. Presence of apolipoprotein E on extracellular neurofibrillary tangles and on meningeal blood vessels precedes the Alzheimer β-amyloid deposition. Acta Neuropathol 1994; 88: 413-419.
14. Verga L, Frangione B, Tagliavini F, Giaccone G, Migheli A, Bugiani O. Alzheimer's and Down's patients: cerebral preamyloid deposits differ ultrastructurally and histochemically from the amyloid of senile plaques. Neurosci Lett 1989; 105: 294-299.
15. Mann DMA, Brown SMP, Owen F, Baba M, Iwasubo T. Amyloid beta protein (Aβ) deposition in dementia with Lewy bodies: predominance of Aβ42/43 and a paucity of Aβ40 compared with sporadic Alzheimer's disease. Neuropathol Appl Neurobiol 1988; 24: 187-194.
16. Fukuda T, Tanaka J, Watabe K, Numoto RT, Minamitani M. Immunohistochemistry of neuronal inclusions in the cerebral cortex and brain stem in Lewy body dementia. Acta Pathol Japon 1993; 43: 545-551.
17. Gai WP, Blumbergs PC, Blessing WW. Microtubule-associated protein-5 is a component of Lewy bodies and Lewy body neurites in the brainstem and forebrain regions affected in Parkinson's disease. Acta Neuropathol 1996; 91: 78-81.
18. Brion JP, Couk AM. Cortical and brain stem type Lewy bodies are immunoreactive for the cyclin dependent kinase-5. Am J Pathol 1995; 147: 1465-1476.
19. Lowe J, Mayer RJ, Landon M. Ubiquitin in neurodegenerative diseases. Brain Pathol 1993; 3: 55-65.
20. Iwatsubo T, Yamaguchi H, Fujinuro M et al. Purification and characterisation of Lewy bodies from the brains of patients with diffuse Lewy body disease. Am J Pathol 1996; 148: 1517-1529.
21. Bayer TA, Jakala P, Hartmann T et al. Alpha-synuclein accumulates in Lewy bodies in Parkinson's disease and dementia with Lewy bodies but not in Alzheimer's disease beta amyloid plaque cores. Neurosci Lett 1999; 266: 213-216.
22. Love S, Saitoh T, Quyada S, Cole GM, Terry RD. Ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies. J Neuropathol Exp Neurol 1988; 47: 393-405.
23. Papp MI, Lantos PL. The distribution of oligodendroglial inclusions in multiple system atrophy and its relevance to clinical symptomology. Brain 1994; 117: 235-243.
24. Spillantini MG, Crowther RA, Jakes R, Cairns NJ, Lantos PL, Goedert M. Filamentous α-synuclein inclusions link multiple system strophy with Parkinson's disease and dementia with Lewy bodies. Neurosci Lett 1998; 251: 205-208.
25. Ksiezak-Reding H, Tracz E, Yang LS, Dickson DW, Simon M, Walt JS. Ultrastructural stability of paired helical filaments from corticobasal degeneration as examined by scanning transmission electron microscopy. Am J Pathol 1996; 149: 639-651.
26. Dickson DW. Neuropathological differentiation of progressive supranuclear palsy and corticobasal degeneration. J Neurol 1999; 246 (Suppl 2): 6-15.
27. Morris HR, Baker M, Yasojima K et al. Analysis of tau haplotypes in Pick's disease. Neurology 2002; 59: 443-445.
28. Cairns NJ, Perry RH, Jaros E et al. Patients with a novel neurofilamentopathy: dementia with neurofilament inclusions. Neurosci Lett 2003; 341: 177-180.
29. Knopman DS. An overview of common non-Alzheimer dementias. Clin Geriatr Med 2001; 17: 281.
30. McKeith IG, Galasko D, Kosaka K et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB): report of the consortium on DLB international workshop. Neurology 1996; 47: 1113-1124.
31. Iseki E, Marin W, Kosaka K, Kato M, Yamamoto T, Ueda K. Clinicopathological multiplicity of dementia with Lewy bodies. Neuropathology 1999; 19: 386-394.
32. Dickson DW, Ruan D, Crystal H et al. Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer's disease: light and electron microscope immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology 1991; 41: 1402-1409.
33. Gibb WR, Luthert PJ, Janota I, Lantos PL. Cortical Lewy body body dementia: clinical features and classification. J Neurol Neurosurg Psychiatr 1989; 52: 185-192.
34. Harrington CR, Perry RH, Perry EK et al. Senile dementia of the Lewy body type and Alzheimer type are biochemically distinct in terms of paired helical filaments and hyperphosphorylated tau proteins. Dementia 1994; 5: 215-228.
35. Mirra SS, Heyman A, McKeel D et al. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991; 41: 479-486.
36. Barber R, McKeith IG, Ballard C, Gholkar A, O'Brien JT. A comparison of medial and lateral temporal lobe atrophy in dementia with Lewy bodies and Alzheimer's disease: magnetic resonance imaging volume trie study. Dement Geriatr Cogn Disord 2001; 12: 198-205.
37. Lobotesis K, Fenwick JD, Phipps A et al. Occipital hypoperfusion on SPECT in dementia with Lewy bodies but not Alzheimer's disease. Neurology 2001; 56: 643-649.
38. Minoshima S, Foster NL, Sima AAF, Frey KA, Abin RL, Kuhl DE. Alzheimer's disease versus dementia with Lewy bodies: cerebral metabolic distinction with autopsy confirmation. Ann Neurol 2001; 50: 358-365.
39. Hansen LA, Salmon D, Galasko D et al. The Lewy body variant of Alzheimer's disease: a clinical and pathological entity. Neurology 1990; 40: 1-8.
40. Szpak GM, Lewandowsk E, Lechowicz W et al. Lewy body variant of Alzheimer's disease and Alzheimer's disease: a comparative immunocytochemical study. Folia Neuropathol 2001; 39: 63-71.
41. Rosenberg CK, Pericak-Vance MA, Saunders AM, Gilbert JR, Gaskell PC, Hulette CM. Lewy body and Alzheimer pathology in a family with the amyloid-beta precursor protein APP717 gene mutation. Acta Neuropathol 2000; 100: 145-152.
42. Raghavan R, Khin-Nu C, Brown A et al. Detection of Lewy bodies in Trisomy 21 (Down's syndrome). Can J Neurol Sci 1993; 20: 48-51.
43. Simon M, van Reekum R. Dementia with Lewy bodies in Down's syndrome. Int J Geriatr Psychiatry 2001; 16: 311-320.
44. Marin W, Iseki E, Kosaka K, Kalo M, Adachi Y, Ueda K. An autopsied case of Down's syndrome with Alzheimer pathology and alpha-synuclein immunoreactivity. Neuropathology 1999; 19: 410-416.
45. Tschampa HJ, Neumann M, Zerr I et al. Patients with Alzheimer's disease and dementia with Lewy bodies mistaken for Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 2001; 71: 33-39.
46. Muramoto T, Kitamoto T, Koga H, Tateishi J. The coexistence of Alzheimer's disease and Creutzfeldt-Jakob disease in a patient with dementia of long duration. Acta Neuropathol 1992; 84: 686-689.
47. El Hachini KH, Cervenakova L, Brown P et al. Mixed features of Alzheimer's disease and Creutzfeldt-Jakob disease in a family with a presenilin 1 mutation in chromosome 14. Amyloid: Int J Exp Clin Invest 1996; 3: 223-233.
48. Armstrong RA, Lantos PL, Cairns NJ. The spatial pattern of prion protein deposits in Creutzfeldt-Jakob disease: comparison with β-amyloid deposits in Alzheimer's disease. Neurosci Lett 2001; 298: 53-56.
49. Dermant B, Cruts M, Backhovens H et al. Familial Creutzfeldt-Jakob disease in a patient carrying both a presenilin 1 missense substitution and a prion protein gene insertion. J Neurol 2000; 247: 364-368.
50. Collins S, McLean CA, Masters CL. Gerstmann-Straussler-Scheinker syndrome, fatal familial insomnia and kuru: a review of these less common human transmissible spongiform encephalopathies. J Clin Neurosci 2001; 8: 387-397.
51. Brun A. Frontal lobe degeneration of the non-Alzheimer's type: neuropathology. Arch Gerontol Geriat 1987; 6: 193-208.
52. Neary D, Snowden JS, Northen B, Goulding P. Dementia of the frontal lobe type. J Neurol Neurosurg Psychiatry 1988; 51: 353-361.
53. Gustafson L. Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis. Arch Gerontol Geriat 1987; 6: 193-208.
54. Talbot P. Fronto-temporal dementia. Alz Rev 1997; 6: 1-5.
55. Jackson M, Lowe J. The new neuropathology of degenerative frontotemporal dementias. Acta Neuropathol 1996; 91: 127-134.
56. Feany MB, Mattiace LA, Dickson DW. Neuropathological overlap of Progressive supranuclear palsy, Pick's disease and corticobasal degeneration. J Neuropathol Exp Neurol 1996; 55: 53-67.
57. Schneider JA, Watts RL, Gearing M, Brewer RP, Mirra SS. Corticobasal degeneration: neuropathology and clinical heterogeneity. Neurology 1997; 48: 959-969.
58. Collinge J, Palmer MS. Prion disease in humans and their relevance to other neurodegenerative diseases. Dementia 1993; 4: 178-185.
59. Reed LA, Schmidt ML, Wszolek ZK et al. The neuropathology of a chromosome 17-linked autosomal dominant parkinosism and dementia ('pallidopontonigral degeneration'). J Neuropath Exp Neurol 1998; 57: 588-601.
60. Grimes DA, Bergeron CB, Lang AE. Motor neuron disease: inclusion dementia presenting as cortical basal ganglionic degeneration. Mov Disord 1999; 14: 674-680.
61. Rubio A, Steinberg K, Figlewicz DA et al. Coexistence of Huntington's disease and familial amylotrophic lateral sclerosis: case presentation. Acta Neuropathol 1996; 92: 421-427.
62. Mahadevan A, Santosh V, Gayatri N et al. Infantile neuroaxonal dystrophy and giant axonal neuropathy: overlap diseases of neuronal cytoskeletal elements in childhood? Clin Neuropathol 2000; 19: 221-229.
63. Tison F, Wenning GK, Daniel SE, Quinn NP. Multiple system atrophy with Lewy bodies. Rev Neurol 1995; 151: 398-403.
64. Takanashi M, Ohta S, Matsuoka S, Mori H, Mizuno Y. Mixed multiple system atrophy and progressive supranuclear palsy: a clinical and pathological report of one case. Acta Neuropathol 2002; 103: 82-87.
65. Alzheimer A. Uber eine eigenartige Erkrankung der Hirnrinde. Allge Zeitsch Psychiatr Psychisch-Gerich Med 1907; 64: 146-148.
66. Graeber MB, Kosel S, Grasbon-Frodl E, Moller HJ, Mahraein P. Histopathology and apolipoprotein E genotype of the first Alzheimer disease patient. Neurogenetics 1998; 1: 223-228.
67. Moller HJ, Graeber MB. The case described by Alois Alzheimer in 1911: historical and conceptual perspectives based on the clinical record and neurohistological sections. Eur Arch Psychiatry Clin Neurosci 1998; 248: 111-122.
68. Pick A. Uber einen weiteren Symptomenkomplex im Rahman der Dementia senilis, bedingt durch umschriebene starkere Hirnatrophie (gemischte Apraxie). Monat Psych Neurol 1906; 19: 97-108.
69. Karenberg A. A long story starting with a short paper: the early history of Pick's disease. Forts Neurol Pysch 2001; 69: 545-550.
70. Jakob A. Uber eigenartige Erkrankungen des Zentralnervensystems mit bemerkenswerten anatomischen Befunden (spastische Pseudosklerose- Encephalomyelopathic mit disseminierten Degenerationsherden). Dtsch Z Nervenheilkd 1921; 70: 132-146.
71. Creutzfeldt HG. Uber eines eigenartige herd-formige Erkrankung des Zentralnervensystems. In: Nissl F, Alzheimer A (eds) Histologische und Histopathologische Arbeiten Uber die Grosshirnrinde. Jena: Gustav Fisher, 1921; 1-48.
72. Spielmeyer W. Die histopathologische Forschung in der Psychiatrie. Klin Wochenschr 1922; 1: 1817-1819.
73. Chui HC, Teng EL, Henderson VW, Moy AC. Clinical subtypes of dementia of the Alzheimer type. Neurology 1985; 35: 1544-1550.
74. Armstrong RA, Myers D. Principal components analysis of Alzheimer's disease based on neuropathological data: a study of 79 patients. Neurosci Res Communs 1992; 11: 1-9.
75. Armstrong RA, Wood L. The identification of pathological subtypes of Alzheimer's disease using cluster analysis. Acta Neuropathol 1994; 88: 60-66.
76. Forstl H, Fischer P. Diagnostic confirmation, severity and subtypes of Alzheimer's disease. Eur Arch Psychiatry Clin Neurosci 1994; 244: 252-260.
77. Chartier-Harlin MC, Crawford F, Houlden H et al. Early onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene. Nature 1991; 353: 844-846.
78. Goate R, Chartier-Harlin MC, Mullan M et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 1991; 349: 704-706.
79. Sherrington R, Rogaev EI, Liang Y et al. Cloning of a gene bearing missense mutations in early onset familial Alzheimer's disease. Nature 1993; 375: 754-760.
80. Levy-Lahad E, Wasco W, Poorkaj P et al. Candidate gene for chromosome 1 familial Alzheimer's disease locus. Science 1995; 269: 973-977.
81. Sorbi S, Forteo P, Tedde A et al. Genetic risk factors in familial Alzheimer's disease. Mech Aging Dev 2001; 122: 1951-1960.
82. Strittmatter WJ, Wiesgraber KH, Huang DY et al. Binding of human apolipoprotein E to synthetic amyloid-β-peptide: isoform specific effects and implications for late-onset Alzheimer's disease. Proc Natl Acad Sci USA 1993; 90: 8098-8102.
83. Ritchie K, Touchon J. Heterogeneity in senile dementia of the Alzheimer type: individual differences, progressive deterioration or clinical subtypes? J Clin Epidemiol 1992; 45: 1391-1398.
84. Vogt BA, Van Hoesen GW, Vogt LJ. Laminar distribution of neuron degeneration in posterior cingulate cortex in Alzheimer's disease. Acta Neuropathol 1990; 80: 581-589.
85. Boller F. Alzheimer's disease and Parkinson's disease: clinical and pathological associations. In: Reisberg B (ed) Alzheimer's Disease: the Standard Reference. London: MacMillan 1883; 295-302.
86. Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 1986; 19: 253-262.
87. Vinters HV. Cerebral amyloid angiopathy and Alzheimer's disease: two entities or one? J Neurol Sci 1992; 112: 1-3.
88. Forstl H, Burns A, Luthert P, Cairns N, Levy R. The Lewy body variant of Alzheimer's disease: clinical and pathological findings. Br J Psychiatry 1993; 162: 385-392.
89. Armstrong RA, Nochlin D, Bird TD. Neuropathological heterogeneity in Alzheimer's disease: a study of 80 cases using principal components analysis. Neuropathology 2000; 1: 31-37.
90. Cummings JL. Cognitive and behavioural heterogeneity in Alzheimer's disease: seeking the neuropathological basis. Neurobiol Aging 2000; 21: 845-861.
91. Stovers NP, Watts RL. Corticobasal degeneration. Seminars in Neurology 2001; 21: 49-58.
92. Boeve BF, Maraganore DM, Parisi JE et al. Pathologic heterogeneity in clinically diagnosed corticobasal degeneration. Neurology 1999; 53: 795-800.
93. Reed LA, Wszolek ZK, Hutton M. Phenotypic correlates in FTDP-17. Neuropathol Aging 2001; 22: 89-107.
94. Suzuki K, Parker CC, Pentchev PG. Niemann-Pick disease type C: neuropathology revisited. Dev Brain Dysfunct 1997; 10: 306-320.
95. Giannakopoulos P, Hof PR, Bouras C. Dementia lacking distinctive histopathology: clinicopathological evaluation of 32 cases. Acta Neuropathol 1995; 89: 346-355.
96. Stanford PM, Shepherd CE, Halliday GM et al. Mutations in the tau gene that cause an increase in 3R tau in fronto-temporal dementia. Brain 2003; 126: 814-826.
97. Zanusso G, Righetti PG, Ferrari S et al. Two dimensional mapping of three phenotype associated isoforms of the prion protein in sporadic Creuzfeldt-Jakob disease. Electrophoresis 2002; 23: 347-355.
98. Zerr I, Schulz-Schaeffer WJ, Giese A et al. Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants. Ann Neurol 2000; 48: 323-329.
99. Puoti G, Giaccone G, Rossi G, Canciani B, Bugiani O, Tagliavini F. Sporadic Creutzfeldt-Jakob disease: co-occurrence of different types of PrPSc in the same brain. Neurology 1999; 53: 2173-2176.
100. Piccardo P, Dlouhy SR, Lievens PMJ et al. Phenotypic variability of Gerstmann-Straussler-Scheinker disease is associated with prion protein heterogeneity. J Neuropathol Exp Neurol 1998; 57: 979-988.
101. Armstrong RA, Cairns NJ, Ironside JW, Lantos PL. Quantitative variations in the pathology of 11 cases of variant Creutzfeldt-Jakob disease (vCJD). Pathophysiology 2002; 8: 235-241.
102. Mullan M, Crawford F. Genetic and molecular advances in Alzheimer's disease. Trends Neurosci 1993; 16: 398-403.
103. Mann DMA, Jones D. Deposition of amyloid A4 protein within the brains of persons with disorders other than Alzheimer's disease and Down's syndrome. Neurosci Lett 1990; 109: 68-75.
104. Price JL, Davis PB, Morris JC, White DL. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease. Neurobiol Aging 1991; 12: 295-312.
105. Delaere P, He Y, Fayet G, Duyckaerts C, Hauw J. βA4 deposits are constant in the brain of the oldest old: an immunocytochemical study of 20 French centurians. Neurobiol Aging 1993; 14: 191-194.
106. Armstrong RA. Beta-amyloid deposition in the medial temporal lobe in elderly non-demented brains and in Alzheimer's disease. Dementia 1995; 6: 121-125.
107. Ohgami T, Kitamoto T, Weidmann A, Beyreuther K, Takeishi J. Alzheimer's amyloid precursor protein-positive degenerative neuritis exist even without Kuru plaques not specific to Alzheimer's disease. Am J Pathol 1991; 139: 1245-1250.
108. Berr C, Hauw JJ, Delaere P, Duyckaerts C, Amouyel P. Apolipoprotein E allele ε4 is linked to increased deposition of the amyloid-β-peptide (Aβ) in cases with or without Alzheimer's disease. Neurosci Lett 1994; 178: 221-224.
109. Gearing M, Schneider JA, Robins RS et al. Regional variation in the distribution of apolipoprotein and Aβ in Alzheimer's disease. J Neuropathol Exp Neurol 1995; 54: 833-841.
110. Hyman BT, West HL, Rebeck GW et al. Quantitative analysis of senile plaques in Alzheimer's disease: observation of log-normal size distribution and molecular epidemiology of difference associated with apolipoprotein E genotype and trisomy 21 (Down's syndrome). Proc Natl Acad Aci USA 1995; 92: 3586-3590.
111. Beffert U, Poirier J. Apolipoprotein E, plaques, tangles and cholinergic dysfunction in Alzheimer's disease. Ann NY Acad Sci 1996; 777: 166-174.
112. Sanan DA, Weisgraber KH, Russell SJ et al. Apolipoprotein E associates with β-amyloid peptide of Alzheimer's disease to form novel monofibrils. J Clin Invest 1994; 94: 860-869.
113. Uttermann G. (1994) The apolipoprotein E connection. Current Biol 1994; 4: 362-365.
114. Oyama F, Shimada H, Oyama R, Ihara Y. Apolipoprotein E genotype, Alzheimer pathologies and related gene expression in the age population. Mol Brain Res 1995; 29: 92-98.
115. Pomora N, Reisberg R, Albers S. Extrapyramidal symptoms in patients with primary degenerative dementia. J Clin Psychopharmacol 1981; 1: 398-400.
116. Hakim AM, Mathieson G. Dementia in Parkinson's disease: neuropathologic study. Neurology 1979; 29: 1209-1214.
117. Appel SH. A unifying hypothesis for the cause of amylotrophic lateral sclerosis, parkinsonism and Alzheimer disease. Ann Neurol 1981; 10: 499-505.
118. Rosser NN. Parkinson's disease and Alzheimer's disease as disorders of the isodendritic core. BMJ 1981; 282: 1588-1590.
119. Armstrong RA, Cairns NJ, Lantos PL. Lewy body and Alzheimer pathology in temporal lobe in dementia with Lewy bodies. Alz Rep 1998; 1: 159-163.
120. Armstrong RA, Cairns NJ, Lantos PL. β-amyloid (Aβ) deposition in the medial temporal lobe of patients with dementia with Lewy bodies. Neurosci Lett 1997; 227: 193-196.
121. Armstrong RA, Cairns NJ, Lantos PL. Laminar distribution of cortical Lewy bodies and neurofibrillary tangles in dementia with Lewy bodies. Neurosci Res Commun 1997; 21: 145-152.
122. Kawanishi C, Suzuki K, Odawara T et al. Neuropathological evaluation and apolipoprotein ε gene polymorphism analysis in diffuse Lewy body disease. J Neurol Sci 1996; 136: 140-142.
123. Armstrong RA, Cairns NJ, Lantos PL. Beta-amyloid deposition in the temporal lobe of patients with dementia with Lewy bodies: comparison with non-demented cases and Alzheimer's disease. Dementia 2000; 11: 187-192.
124. Lin SH, Zhao JX, Jiang XM, Yao ML, Song XN. Coexistence of Creutzfeldt-Jakob disease and Alzheimer's disease in the same patient. Chinese Med J 1998; 111: 756-758.
125. Salazar AM, Brown P, Gajdusek DC, Gibbs CJ. Relation to Creutzfeldt-Jakob disease and other unconventional virus diseases. In: Reisberg B (ed) Alzheimer's Disease. The Standard Reference. London: MacMillan, 1983; 311-318.
126. Armstrong RA, Cairns NJ, Lantos PL. What does the study of spatial patterns of pathological lesions tell us about the pathogenesis of neurodegenerative disorders? Neuropathology 2001; 21: 1-12.
127. Gaches J, Supino-Viterbo V, Foncin JF. Association des maladies d'Alzheimer et de Creutzfeldt-Jakob. Acta Neurol Belg 1977; 77: 202-212.
128. Kretzschmar HA, Neumann M. Neuropathological diagnosis of neurodegenerative and dementing disorders. Pathologe 2000; 21: 364-374.
129. Dickson DW. Neuropathology of Alzheimer's disease and other dementias. Clin Geriatr Med 2001; 17: 209.
130. Trojanowski JQ, Clark CM, Schmidt ML, Arnold SE, Lee VMY. Strategies for improving the post-mortem neuropathological diagnosis of Alzheimer's disease. Neurobiol Aging 1997; 18 (Suppl 1): S75-S79.
131. Poser S, Mollenhauer B, Krauss A et al. How to improve the clinical diagnosis of Creutzfeldt-Jakob disease. Brain 1999; 122: 2345-2351.
132. Vuillaume I, Schraen S, Rousseaux J, Sablonniere B. Simple nonisotopic assays for detection of (CAG)n repeats expansions associated with seven neurodegenerative disorders. Diagn Mol Pathol 1998; 7: 174-179.
133. Stevanin G, Durr A, Brice A. Clinical and molecular advances in autosomal dominant cerebeller ataxias. from genotype to phenotype and physiopathology. Eur J Hum Genet 2000; 8: 4-18.
134. Brice A. Unstable mutations and neurodegenerative disorders. J Neurol 1998; 245: 505-510.
135. Wakabayashi K, Hayashi S, Kakita A et al. Accumulation of alpha-synuclein/NACP is a cytopathological feature common to Lewy body disease and multiple systems atrophy. Acta Neuropathol 1998; 96: 445-452.
136. Litvan I, DeLeo JM, Hauw JJ et al. What can artificial neural networks teach us about neurodegenerative disorders with extrapyramidal features? Brain 1996; 119: 831-839.
137. Pirker W, Asenbaum S, Bencsits G et al. [I-123] beta-CITSPECT in multiple systems atrophy, progressive supranuclear palsy and corticobasal degeneration. Mov Disord 2000; 15: 1158-1167.
138. Wallin A, Blennow K. Clinical subgroups of Alzheimer's syndrome. Acta Neurol Scand 1996; 93: 51-57.
139. Jellinger KA, Bancher C. Neuropathology of Alzheimer's disease: a critical update. J Neural Transm 1998; 54: 77-95.
140. Kertesz A, Kalvach P. Arnold Pick and German neuropsychiatry in Prague. Arch Neurol 1996; 53: 935-938.
141. Forstl H, Baldwin B. Pick and the focal brain atrophies. Fortschr Neurol Psychiatr 1994; 62: 345-355.
142. Kirschbaum WR. Jakob-Creutzfeldt Disease (Spastic Psuedosclerosis, a Jakob; Heidenhain Syndrome; Subacute Spongiform Encephalopathy. New York: Elsevier 1968.
143. Aguzzi A, Weissmann C. Prion research: the next frontier. Nature 1997; 389: 795-798.
144. Chesebro B. BSE and prions: uncertainties about the agent. Science 1998; 279: 42-43.
145. Barber R, Scheltens F, Gholkar A et al. White matter lesions on MRI in dementia with Lewy bodies, Alzheimer's disease, vascular dementia and normal aging. J Neurol Neurosurg Psychiatry 1999; 67: 66-72.
146. Armstrong RA, Cairns NJ, Lantos PL. Are pathological lesions in neurodegenerative disorders the cause or the effect of the degeneration? Neuropathology 2002; 22: 114-127.
147. Armstrong RA, Cairns NJ, Lantos PL. Laminar distribution of Pick bodies, Pick cells and Alzheimer's disease pathology in the frontal and temporal cortex in Pick's disease. Neuropathol Appl Neurobiol 1999; 25: 266-271.
148. Ince PG, Lowe J, Shaw PJ. Amylotrophic lateral sclerosis: current issues in classification, pathogenesis and molecular pathology. Neuropathol Appl Neurobiol 1998; 24: 104-117.
149. Arai H, Noguchi I, Makino Y, Kosaka K, Herzmann CW, Ilzuka R. Parvalbumin-immunoreactive neurons in the cortex in Pick's disease. J Neurol 1991; 238: 200-202.
150. Hardy JA. Lewy bodies in Alzheimer's disease in which the primary lesion is a mutation in the amyloid precursor protein. Neurosci Lett 1994; 180: 290-291.